Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Cutaneous complications of cyclosporine: a case of drug-induced folliculitis in atopic dermatitis

    Mohammad Al-Haddab, Rema Alkahtani, Faisal BinKhonain, Amany Fathaddin
    09-05-2025
    https://doi.org/10.4081/dr.2025.10242
    1004
    PDF: 335
    HTML: 21
  • Scleredema diabeticorum

    Mariana Pereira, Rita Ramos Pinheiro, André Lencastre, Elvira Bártolo
    21-11-2022
    https://doi.org/10.4081/dr.2022.9477
    2560
    PDF: 803
    HTML: 178
  • Translation and validation of patient-oriented eczema measure in the Greek language

    Garyfallia Stefanou, Stamatios Gregoriou, Mihalis Bakakis, Styliani Mastraftsi, Alexandros Stratigos, Stathis Kontodimas, Konstantinos Sfaelos, Georgia Kourlaba
    11-10-2023
    https://doi.org/10.4081/dr.2023.9689
    928
    PDF: 538
    HTML: 33
  • Efficacy of a topical polyphenol-based formulation in palmoplantar psoriasis: an observational study

    Simone Amato, Annunziata Dattola, Luigi Bennardo, Martina Tolone, Steven Paul Nisticò
    08-07-2025
    https://doi.org/10.4081/dr.2025.10333
    593
    PDF: 401
    HTML: 47
  • 11 | EFFICACY AND SAFETY OF LEBRIKIZUMAB IS MAINTAINED UP TO 4 YEARS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: FIRST YEAR OF ADLONG LONG-TERM EXTENSION TRIAL L. Stingeni1, S. Weidinger2, A. Irvine3, D. Thaçi4, J. Szepietowski5, T. Biedermann6, H. Agell7, Y. Mihaylov7, B. Kostov7, R. Coll7, W. Romero8, K. Reich9 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; 3Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 4Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 5Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland; 6Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany; 7Almirall S.A., Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11078
    141
    PDF: 85
  • Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

    Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo
    12-07-2022
    https://doi.org/10.4081/dr.2022.9267
    1143
    PDF: 540
    Supplementary Table: 256
    HTML: 26
  • Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after checkpoint inhibitor treatment: a case report

    Carlotta Bertolina, Marinella Bertolotti, Claudia Leporati, Antonina Maria De Angelis, Sara Delfanti, Luigi Cerbone, Marco Ghiglione, Federica Grosso
    17-06-2025
    https://doi.org/10.4081/dr.2025.10324
    636
    PDF: 362
    HTML: 35
  • 10 | LEBRIKIZUMAB PROVIDES CLINICALLY MEANINGFUL RESPONSE IN FACE AND HANDS IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ADHOPE 1 STUDY L. Stingeni1, C. Vestergaard2, J. Seneschal3|4, S. Weidinger5, A. Wollenberg6|7|8, A. Irvine9, H. Agell10, J. Valls Bancells10, V. Sapena10, D. Thaçi7 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Dermatology, University of Bordeaux, Bordeaux, France; 4Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, France; 5Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany; 6University Medical Center of Augsburg, Augsburg, Germany; 7Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 8Department of Dermatology and Allergology, LMU Hospital, Munich, Germany; 9Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 10Almirall S.A., Barcelona, Spain

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11077
    231
    PDF: 161
  • Acne exacerbation after tofacitinib treatment for alopecia areata

    Sawsan Alharthi, Mohammed G. Turkmani, Mohammed I. AlJasser
    01-01-2022
    https://doi.org/10.4081/dr.2022.9396
    2695
    PDF: 900
    HTML: 45
51 - 59 of 59 items << < 1 2 3 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.